



Sickle cell disease (SCD) is a heterogeneous group of 
autosomal recessive structural hemoglobin disorder with a 
highly variable clinical spectrum. The most prevalent form 
is sickle cell anemia (HbSS), which is due to the inheritance 
of the sickle gene in a homozygous state.[1] Other forms of 
SCD include the compound heterozygous forms, in which the 
sickle beta-globin gene is co-inherited with another abnormal 
hemoglobin gene such as HbC, β-thalassemia, and HbD among 
others.[2]
SCD is the most common genetic disorder worldwide. The 
global prevalence of SCD is 20–25 million, and about 12–15 
million affected persons are in Sub-Sahara Africa.[3] The WHO 
estimated that 300,000 children are born annually with SCD, 
75% of whom are in Sub-Saharan Africa. In Nigeria, >150,000 
children are born with this disease annually. The overall 
prevalence of SCD in Nigeria is estimated to be between 2% 
and 3%; with slight variations from one region to another. 
Akaba et al. reported a prevalence of 2.28% in South-South 
Nigeria. Similarly, a prevalence of 2.4% SCD was reported 
in South-west Nigeria.[4]
SCD is characterized by numerous complications which 
affect every organ and or tissues in the body, often chronic 
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in the long term. Chronic complications range from 
chronic pain, cerebro-vascular disease/stroke, pulmonary 
hypertension, leg ulcers, avascular necrosis (AVN), 
retinopathy, renal failure, and hepatopathy. Chronic 
complications can be attributed to the vicious cycle of 
sickling, which causes endothelial injury, inflammation, 
oxidative stress, and hypercoagulability, leading to a 
vasculopathy.[5] The aim of this study is to bring a paradigm 
shift from routine treatment of acute events in SCD to the 
more devastating chronic complications associated with 
morbidity and mortality, through the determination of the 
prevalence of chronic complications encountered by sickle 
cell anemia (SCA) patients at the UCTH, Calabar.
Methodology
Study design
This was a cross-sectional hospital-based study involving 
sickle cell anemia patients, carried out between July 2017 
and June 2018.
Study area
This study was carried out at the adult hematology 
clinic of the Department of Haematology and Blood 
Transfusion, of the University of Calabar Teaching Hospital, 
government-owned tertiary institution situated in Calabar. 
The hematology unit is manned by Consultants, supported 
by; Resident Doctors, Trained Nurses, Medical Laboratory 
Scientists and Allied Staff, the unit also has a comprehensive 
medical records.
Subject
The study population comprises adults with SCA.
Sample size
A total of 60 SCA patients participated in the study.
Selection criteria
• Inclusion– All adults subjects who carry the SS gene 
attending the adult SCA clinic of the hospital
• Exclusion– All other hemoglobin genes
• Those with deformity following trauma or other condition 
not due to the sickle cell.
Methods
All patients who presented at the SCD clinic during the 
period of the study were given a questionnaire that captures 
their biodata and clinical information, which included any 
forms of chronic complication. All eligible participants 
underwent a comprehensive multisystemic examination 
to ascertain their complications. Other information 
regarding chronic complications was obtained from their 
records at the Adult Haematology Clinic, Department of 
Haematology, UCTH. A blood sample was collected into 
an ethylenediaminetetraacetic acid bottle for hemoglobin 
electrophoresis were those with the homozygous SS gene 
were reconfirmed after informed consent to participate in 
the study was administered.
Results
The median age of the participants was 23 ± 13.6 years. The 
participants consisted of 23 (38.30%) males and 37 (61.70%) 
females. Majority (86.70%) were single, while the remaining 
13.30% were married. Most of the participants had tertiary 
education (73.30%), whereas the rest (26.60) had only 
secondary education [the demographic characteristics of 
the participants are shown in Table 1]. The most prevalent 
complication was AVN with a prevalence of 8.33%, followed 
by retinopathy (6.67%), while pulmonary hypertension and 
leg ulcers had a prevalence of 5%, respectively [Figure 1]. 
The least frequent complications were nephropathy, stroke, 
and hepatopathy, all with a prevalence of 3.33%. There was no 
observable significant statistical difference in the association 
between gender and chronic complications among adult SCA 
patients.
dIscussIon
The rising trend of chronic complications among adult SCA 
patients with the attendant increased morbidity and mortality 
poses a great challenge to both patients and caregivers. This 
study shows the profile and spectrum of chronic complications 
seen in adult patients with SCA attending a tertiary hospital in the 
South-South region of Nigeria. This study seems to be the first 
of its kind to describe the prevalence of chronic complications 
encountered by adult SCA patients in the South-South region of 
Nigeria. This rising trend of chronic complications among adult 
SCA patients in our study could be attributed to vasculopathy, 
which might have resulted from the vicious cycle of repeated 
inflammation, endothelial injury, oxidative stress, and 
hypercoagulability observed by earlier workers.[6]
Our study shows female preponderance with an M: F ratio 
of 1:1.6; this could be attributed to the good health-seeking 
behavior of females [Table 2]. Majority of the females in this 
study being single may be due to the social stigmatization of 
the SS gene individuals. Most of the SCA have attained tertiary 
education; this can also be attributed to the proximity of the 
hospital to a tertiary institution.

























































Figure 1: The distribution of chronic complications among adult sickle 
cell anemia patients
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Most of our SCA patients were <40-years and the median 
age of the study population was 23 years. This may be 
due to the reduced life expectancy in patients with SCA in 
Sub-Sahara Africa[7] compared to the life expectancy of SCA 
in developed countries, which is >40 years.[8] The reduced life 
expectancy may be due to poverty, malaria, increase in the 
prevalence of communicable disease, illiteracy, lack of policy 
on routine newborn screening, limited access to healthcare, 
and disease-modifying drugs.[9]
AVN was the leading chronic complication encountered in our 
study, with a prevalent rate of 8.83%, and male preponderance 
with an M: F of 1.5:1. AVN is the leading cause of disability in 
SCA patients and invariably affects their quality of life.[10] In 
sharp contrast, Ladu et al., in a related study, reported a higher 
prevalence of 16.1%.[11] Similarly, other studies also reported 
a prevalence of 42%–48%.[12,13] In like manner, Balogun et al. 
reported a prevalence of 31.4% in South-West Nigeria.[14] 
The observed difference in the prevalence of AVN from the 
different regions could be attributed to the difference in study 
design and sample size. AVN is said to develop with age and 
common in the male gender.[14] AVN is also associated with 
hematocrit and high steady-state platelet count[15] because 
this leads to hyperviscosity within the sinusoids, which 
promote the sickling of the red cells, resulting in ischemia 
and subsequent infarction.
Retinopathy was the next most common chronic complication 
encountered in our study population, with a prevalence of 
6.67%, with an M: F of 1:1. Retinopathy is reported more 
commonly in HbSc and HbS + thalassemia than HbSS due 
to the higher degree of fluid viscosity in the former.[16,17] In 
contrast to our study, Andong et al. reported a much higher 
prevalence of 26.9%,[18] while another study conducted in 
Accra, Ghana reported a prevalence of 3.5%.[19] Furthermore, 
a study conducted in Port-Harcourt, in South-South Nigeria, 
reported a prevalence of 34.0%. These large differences can 
be attributed to the study design and sample size.[20]
Pulmonary hypertension was also observed in 5.0% of our 
study population, with a female preponderance, M: F of 
1:0.5, by the elevated Tricuspid Regurgitation Velocity. 
This is similar to the national prevalence rate of 3%–25% 
pulmonary hypertension in adult SCA in Nigeria.[21,22] Thus, 
the gold standard for determining pulmonary hypertension is 
the use of right heart catheterization, not readily available in 
our environment.
Leg ulcers in our index study reported a prevalence of 5%, 
with a male preponderance at a ratio of 1:0.5. This concurred 
with the findings of several studies conducted in Nigeria, in 
which leg ulcers range from 3% to 16%.[10,23-26] In variance 
to this study, a lower rate of 2.5% was reported in the United 
States,[27] while a significantly higher rate of 40% was 
reported among adult SCA patients in Jamaica. This variation 
may be attributed to the study population, sample size 
hemoglobin genotype, haplotype, and geographical location. 
There are several factors associated with the development 
of chronic leg ulcers; these include trauma, age (>20 years), 
sex (male), low hematocrit, and fetal hemoglobin level. The 
presence of chronic leg ulcers is also a known determinant 
of the severity of SC disease.[28] This complication requires 
a multidisciplinary management approach and safe blood 
transfusion.[29]
Nephropathy is also a form of chronic complication in SCA 
patients encountered in our study population, with a prevalence 
of 3.33% and female preponderance. This was lower than 
the reported prevalence of (20%–50%) from several studies 
in Nigeria.[30-32] This difference can be attributed to the study 
design. Renal involvement is a well-known documented 
complication of SCA.[33,34] The hypoxic, acidotic, and 
hypertonic state of the renal medulla favors vaso-occlusion, 
thereby affecting the medullary vasa recta. Early in life, SCD 
infants may develop hypothermia which might manifest as 
nocturia enuresis.[24] Studies have shown that the prevalence 
of enuresis is higher in SCA. Some studies have shown that 
increasing age, high hematocrit, high blood pressure, and 
Table 1: The sociodemographic characteristics of the 
participants

















Table 2: Gender distribution and chronic complications 
among adult sickle cell anemia patients
Complication Male Female Total (%) Statistics
Retinopathy 2 2 4 (6.67) χ2=4.531, P=0.424
Nephropathy 0 2 2 (3.33)
AVN 3 2 5 (8.33)
Leg ulcer 2 1 3 (5.00)
Pulmonary HTN 1 2 3 (5.00)
Stroke 0 2 2 (3.33)
Hepatopathy 1 1 2 (3.33)
None 14 25 39 (65.00)
Total 23 37 60
No statistical difference was observed in the association between chronic 
complications in sickle cell disease and gender χ2 (6)=4.531, P=0.424. 
AVN: Avascular necrosis, HTN: Hypertension
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history of blood transfusion are associated with the risk of 
developing sickle cell kidney disease.[31,34]
Stroke, a fatal complication of SCA, was among the least 
encountered complications in this study, with a prevalence 
of 3.33%, with an overall female preponderance. Stroke is 
associated with significant morbidity and mortality in SCA.[35] 
SCA patients with stroke suffer a sudden onset of focal or global 
neurologic deficit of vascular origin lasting >24 h. A higher 
prevalence of 4.3% and 5.2% were reported in Port-Harcourt 
and Abuja, respectively.[36,37] This variation could be attributed 
to the difference in the study designs. The risk of stroke is said 
to be higher in those with low baseline hemoglobin, low fetal 
hemoglobin high white cell count, and high systolic blood 
pressure, higher in HbSS compared to the heterozygous forms 
and compound heterozygous forms. This complication requires 
a multidisciplinary management approach, exchange blood 
transfusion being pivotal.[29]
Hepatobiliary system involvement was among the least 
chronic complications of SCD among adult patients in this 
study, with an M: F ratio of 1:1. This complication in SCD 
is caused by transfusion transmissible infection, transfusion 
siderosis, intrahepatic trapping of sickled cells. In the current 
study, a prevalence of 3.33% was reported, which was similar 
to the studies reported by Solomon[38] and Fashola et al.[39] 
Risk factors that can influence hepatobiliary complications, 
especially cholelithiasis are local diet, genetic factors, 
crystallization of gallstone by ceftriaxone.[40]
conclusIon
The authors have concluded that adult SCA patients develop 
chronic complications ranging from a more frequent AVN 
to the least common hepatobiliary affectation. Prompt 
multidisciplinary interventions in the management of adults 
with SCA improve quality of life
Limitation
Financial constraints and inadequate available diagnostic 
equipment prevented further molecular evaluation of SCD 
patients with chronic complications
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